MAKE PROTECTION YOUR SUPERPOWER
Elevate your expertise
at PRIME.
Discover the role of SGLT2 inhibitors in enhancing
cardiorenal metabolic health and patient outcomes.
PRIME Summit 2
From screening to protection: Advancing cardiorenal metabolic care with SGLT2 inhibitors
July 27, 2024 (Saturday) | 17:30 – 19:40 MYT
Grand Intercontinental Parnas, Seoul, South Korea
Speakers
Merlin Thomas
Endocrinologist
Monash University
Australia
Javed Butler
Cardiologist
Baylor Scott and White Research Institute
United States
Jeong Hyun Park
Endocrinologist
Inje University Busan Paik Hospital
Korea
Mi-kyung Kim
Endocrinologist
Haeundae Paik Hospital, Inje University
Korea
Agenda
| Time | Topic | Speaker |
|---|---|---|
| 17:30 - 17:35 | Introduction to day 1 | Co-Chairs: Jeong Hyun Park Merlin Thomas |
| 17:35 - 17:50 | The ties that bind | Javed Butler |
| 17:50 - 18:10 | Case discussion
| Case presenter: Merlin Thomas Moderator: Jeong Hyun Park Panelists: Mikyung Kim Merlin Thomas Javed Butler |
| 18:10 - 18:25 | Managing the double trouble: Evidence and recommendations of SGLT2 inhibitors in diabetes-related chronic kidney disease | Merlin Thomas |
| 18:25 - 18:45 | Live Q & A | Moderator: Jeong Hyun Park Panelists: Merlin Thomas Mikyung Kim Javed Butler |
| 18:45 - 19:00 | Case discussion
| Case presenter: Merlin Thomas Moderator: Jeong Hyun Park |
| 19:00 - 19:15 | Optimal glycemic control in type 2 diabetes: The role of early initiation of SGLT2i and DPP4 inhibitor combination therapy | Mikyung Kim |
| 19:15 - 19:35 | Live Q & A | Moderator: Jeong Hyun Park Panelists: Merlin Thomas Mikyung Kim Javed Butler |
| 19:35 - 19:40 | Closing: Take 5 key takeaways | Jeong Hyun Park |